Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Jun. 30, 2026
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Fred Thiel [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On June 9, 2026, Fred Thiel, the Company’s Chief Executive Officer and Chairman of the Board of Directors, entered into a trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (a “10b5-1 Plan”). Mr. Thiel’s 10b5-1 Plan provides for the potential sale of up to 330,060 shares of the Company’s common stock between the first potential sale date on October 1, 2026 and the expiration of the 10b5-1 Plan on September 30, 2027. Mr. Thiel’s existing 10b5-1 Plan will expire on September 30, 2026.
|
| Name | Fred Thiel |
| Title | Chief Executive Officer and Chairman of the Board of Directors |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | June 9, 2026 |
| Expiration Date | September 30, 2027 |
| Arrangement Duration | 364 days |
| Aggregate Available | 330,060 |
| Douglas Mellinger [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On June 9, 2026, Douglas Mellinger, the Lead Independent Director on the Company’s Board of Directors, entered into a 10b5-1 Plan. Mr. Mellinger’s 10b5-1 Plan provides for the potential sale of up to 15,000 shares of the Company’s common stock between the first potential sale date on September 10, 2026 and the expiration of the 10b5-1 Plan on November 30, 2027. Mr. Mellinger’s prior 10b5-1 Plan expired on June 30, 2026.
|
| Name | Douglas Mellinger |
| Title | Lead Independent Director on the Company’s Board of Directors |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | June 9, 2026 |
| Expiration Date | November 30, 2027 |
| Arrangement Duration | 446 days |
| Aggregate Available | 15,000 |